Posted by on Nov 20, 2016 in Urinary incontinence | 0 comments

In a nutshell This study analyzed onabotA (onabotulinumtoxinA [Botox]) in treating overactive bladder symptoms (OABs). Authors reported that onabotA significantly reduced OABs and can be recommended as a third-line therapy. Some background Bladder muscle overactivity is characterized by urinary urgency and is often associated with urinary...

Read More